Soligenix Achieves Successful Transfer of Synthetic Hypericin Manufacturing to the U.S. Soligenix has transferred the manufacturing of synthetic hypericin to the U.S., paving the way for clinical trials and commercialization of treatments for CTCL and psoriasis.

Soligenix Achieves Successful Transfer of Synthetic Hypericin Manufacturing to the U.S. #United_States #Princeton #Soligenix #HyBryte #Synthetic_Hypericin